跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVA-ARIPIPRAZOLE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TEVA-ARIPIPRAZOLE
Authorized
STANDARD
TEVA-ARIPIPRAZOLE
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
74c18d9763fbefe2
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
74c18d9763fbefe2
Drug Approval Canada Name
TEVA-ARIPIPRAZOLE
Product Name
TEVA-ARIPIPRAZOLE
Status
Cancelled Post Market
Status Date
2021-07-29
Original Market Date
2018-07-17
Din
02464144
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.08.04
Atc Original
N05AX12 ARIPIPRAZOLE
Atc Name
n 05 ax 12
Aig Number
0152514001
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
ARIPIPRAZOLE
2 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
74c18d9763fbefe2
Type
Standard
Back to Health Canada Approvals